发明名称 FORMULATION
摘要 THE INVENTION RELATES TO A NOVEL SUSTAINED RELEASE PHARMACEUTICAL FORMULATION ADAPTED FOR ADMINISTRATION BY INJECTION CONTAINING THE COMPOUND 7X-[9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL) NONYL]OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL, MORE PARTICULARLY TO A FORMULATION ADAPTED FOR ADMINISTRATION BY INJECTION CONTAINING TO COMPOUND 7a-[9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL) NONYL] OESTRA- 1,3,5 (10)-TRIENE-3,17B-DIOL IN SOLUTION IN A RICINOLEATE VEHICLE WHICH ADDITIONALLY COMPRISES AT LEAST ONE ALCOHOL AND A NON-AQUEOUS ESTER SOLVENT WHICH IS MISCIBLE IN THE RICINOLEATE VEHICLE.
申请公布号 MY118583(A) 申请公布日期 2004.12.31
申请号 MY2001PI00107 申请日期 2001.01.10
申请人 ASTRAZENECA AB 发明人 JOHN RAYMOND EVANS;ROSALIND URSULA GRUNDY
分类号 A61K9/08;A61K;A61K9/00;A61K31/565;A61K31/5685;A61K36/47;A61K47/00;A61K47/10;A61K47/12;A61K47/14;A61K47/44;A61P;A61P5/32;A61P15/00;A61P35/00;C07J31/00 主分类号 A61K9/08
代理机构 代理人
主权项
地址